Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
ABVC BioPharma, Inc. (ABVC) had Receiveable Turnover of 12.71 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$0.15M |
|
$-10.52M |
|
$0.30M |
|
$-0.15M |
|
$8.37M |
|
$-8.22M |
|
$-2.44M |
|
$-10.65M |
|
$-10.43M |
|
$-10.91M |
|
$-10.91M |
|
$-10.91M |
|
$-10.69M |
|
$-8.22M |
|
$-8.19M |
|
4.34M |
|
4.34M |
|
$-2.43 |
|
$-2.43 |
|
Balance Sheet Financials | |
$1.66M |
|
$7.97M |
|
$12.84M |
|
$14.49M |
|
$5.93M |
|
-- |
|
$0.43M |
|
$6.36M |
|
$8.13M |
|
$8.13M |
|
$8.13M |
|
7.91M |
|
Cash Flow Statement Financials | |
$-4.24M |
|
$-0.36M |
|
$3.92M |
|
$1.39M |
|
$0.72M |
|
$-0.67M |
|
$1.64M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.28 |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-98.15% |
|
-5390.35% |
|
-5390.35% |
|
-5371.63% |
|
-6989.62% |
|
-6898.68% |
|
$-4.26M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
Receiveable Turnover |
12.71 |
28.72 |
|
-134.18% |
|
-134.18% |
|
-75.28% |
|
-134.18% |
|
$1.03 |
|
$-0.98 |
|
$-0.98 |